Table 1 |
||
|
Clinical characteristics of the SLE patients at the time point of blood sampling |
||
|
Characteristics |
SLE (n = 63) |
Control (n = 33) |
|
|
||
|
Age, median (range), years |
42 (19 to 81) |
45 (24 to 79) |
|
Female, % |
94 |
85 |
|
Male, % |
6 |
15 |
|
Disease duration, median (range), years |
8 (0 to 45) |
- |
|
SLEDAI score, median (range) |
2 (0 to 18) |
- |
|
Seizure |
0 |
- |
|
Psychosis |
0 |
- |
|
Organic brain syndrome |
0 |
- |
|
Visual disturbance |
1 |
- |
|
Cranial nerve disorder |
1 |
- |
|
Lupus headache |
0 |
- |
|
Cerebrovascular accident |
0 |
- |
|
Vasculitis |
3 |
- |
|
Arthritis |
8 |
- |
|
Myositis |
1 |
- |
|
Kidney involvement (urinary cast, hematuria, proteinuria or pyuria) |
14 |
- |
|
Mucocutaneous activity (rash, alopecia or mucosal ulcers) |
12 |
- |
|
Pleurisy |
0 |
- |
|
Pericarditis |
0 |
- |
|
Low complement (C3 or C4) |
14 |
- |
|
Anti-DNA antibodies |
14 |
- |
|
Fever |
2 |
- |
|
Thrombocytopenia |
1 |
- |
|
Leukopenia |
2 |
- |
|
|
||
|
Items included in SLE disease activity (SLEDAI) are shown. |
||
|
Lood et al. Arthritis Research & Therapy 2011 13:R60 doi:10.1186/ar3314 |
||
